Paul Romness MHP - CEO OS Therapies

<p>In this episode of the <a class="ql-mention" spellcheck="false" href= "https://www.linkedin.com/feed/?trk=homepage-basic_signin-form_submit" data-entity-urn="urn:li:fsd_company:81481808" data-guid="87" data-object-urn="urn:li:organization:81481808" data-original-text= "Life Science Success Podcast">Life Science Success Podcast</a> from Bio in the Bayou 2022, I sit down with <a class="ql-mention" spellcheck="false" href= "https://www.linkedin.com/feed/?trk=homepage-basic_signin-form_submit" data-entity-urn= "urn:li:fsd_profile:ACoAABJG7m4Bb47Is-mCp9jU2GbRmA49OpMN-Wk" data-guid="88" data-object-urn="urn:li:member:306638446" data-original-text="Paul Romness">Paul Romness</a> the founder of <a class="ql-mention" spellcheck="false" href= "https://www.linkedin.com/feed/?trk=homepage-basic_signin-form_submit" data-entity-urn="urn:li:fsd_company:33258227" data-guid="89" data-object-urn="urn:li:organization:33258227" data-original-text= "OS Therapies">OS Therapies</a>. During our interview Paul shares his absolute passion for Osteosarcoma. He shares that roughly 1000 children will get osteosarcoma each year and roughly 50% will die. (Paul agreed to let me share the emotion expressed during the interview)</p> <p> </p> <p>I greatly appreciate companies that are attacking problems like this and look forward to seeing <a class="ql-mention" spellcheck= "false" href= "https://www.linkedin.com/feed/?trk=homepage-basic_signin-form_submit" data-entity-urn="urn:li:fsd_company:33258227" data-guid="90" data-object-urn="urn:li:organization:33258227" data-original-text= "OS Therapies">OS Therapies</a> in the news as they go public.</p>